- £1.97m
- £1.01m
- £0.05m
- 12
- 23
- 36
- 10
RCS - ValiRx PLC - ValiRx launches new interactive investor website
AnnouncementREG - ValiRx PLC - Broker Offer Results & Director/PDMR Subscription
AnnouncementREG - ValiRx PLC - Posting of Circular and Notice of General Meeting
AnnouncementREG - ValiRx PLC - Conditional Fundraising & Launch of Broker Offer
AnnouncementREG - ValiRx PLC - Inaphaea award of HEIF Funding and PhD sponsorship
AnnouncementREG - ValiRx PLC - Update on proposed sub-license of VAL401
AnnouncementREG - ValiRx PLC - Contract Award
AnnouncementREG - ValiRx PLC - First Sale of New Product Line
AnnouncementREG - ValiRx PLC - Update on proposed sub-license of VAL201
AnnouncementREG - ValiRx PLC - Directorate Change
AnnouncementREG - ValiRx PLC - Investor Webinar
AnnouncementREG - ValiRx PLC - Inaphaea Co-Marketing Agreement
AnnouncementREG - ValiRx PLC - Half-year Report
AnnouncementREG - ValiRx PLC - Conclusion of Evaluation Project
AnnouncementREG - ValiRx PLC - Inaphaea Co-Marketing Agreement
AnnouncementREG - ValiRx PLC - Inaphaea Evaluation and Commercial Use Agreement
AnnouncementREG - ValiRx PLC - Inaphaea Co-Marketing Agreement
AnnouncementREG - ValiRx PLC - Investor Evening
AnnouncementREG - ValiRx PLC - Inaphaea Evaluation and Commercial Use Agreement
Announcement